Genital porokeratosis: Treatment with diclofenac topical gel

Journal of Dermatological Treatment

Volumn 18, Issue 3, 2007, Pages 188-190

  Kluger, Nicolas ^a   Dereure, Olivier ^a   Guilhou, Jean Jacques ^a   Guillot, Bernard ^a,b  

^a UNIV MONTPELLIER   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

Diclofenac sodium; Genitalia; Porokeratosis

Indexed keywords

BETAMETHASONE; COLECALCIFEROL; DICLOFENAC; DIFLUCORTOLONE; IMIQUIMOD; TAZAROTENE;

AGED; ANAMNESIS; ARTICLE; BIOPSY; CASE REPORT; CLINICAL FEATURE; EVOLUTION; GENITAL SYSTEM DISEASE; HUMAN; HUMAN TISSUE; MALE; POROKERATOSIS; PRIORITY JOURNAL;

ADMINISTRATION, CUTANEOUS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIAGNOSIS, DIFFERENTIAL; DICLOFENAC; GELS; HUMANS; MALE; POROKERATOSIS; SCROTUM;

EID: 34249829606     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630701258101     Document Type: Article

References (9)

1. Chen TJ, Chou YC, Chen CH, Kuo TT, Hong HS. Genital porokeratosis: A series of 10 patients and review of the literature. Br J Dermatol. 2006;155:325-9.
2. Huang SL, Liu YH, Chen W. Genitogluteal porokeratosis. J Eur Acad Dermatol Venereol. 2006;20:899-900.
3. Schamroth JM, Zlotogorski A, Gilead L. Porokeratosis of Mibelli. Overview and review of the literature. Acta Derm Venereol. 1997;77:207-13.
4. Agrawal SK, Gandhi V, Madan V, Bhattacharya SN. Topical tretinoin in Indian male with zosteriform porokeratosis. Int J Dermatol. 2003;42:919-20.
5. Bohm M, Luger TA, Bonsmann G. Disseminated superficial actinic porokeratosis: Treatment with topical tacalcitol. J Am Acad Dermatol. 1999;40:479-80.
6. Cavicchini S, Tourlaki A. Successful treatment of disseminated superficial actinic porokeratosis with methyl aminolevulinate-photodynamic therapy. J Dermatolog Treat. 2006;17:190-1.
7. Arranz-Salas I, Sanz-Trelles A, Ojeda DB. p53 alterations in porokeratosis. J Cutan Pathol. 2003;30:455-8.
8. Kim KH, Park EJ, Seo YJ, Cho HS, Kim CW, Kim KJ, et al. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors. J Dermatol. 2006;33:319-25.
9. Nelson C, Rigel D, Smith S, Swanson N, Wolf J. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). J Drugs Dermatol. 2004;3:401-7.